Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Recent advances in exosome-based immunotherapy applied to cancer
Jindong Xie, Zihan Zheng, Ling Tuo, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 27

Showing 1-25 of 27 citing articles:

Tumor-derived Exosomal ENO2 Modulates Polarization of Tumor-associated Macrophages through Reprogramming Glycolysis to Promote Progression of Diffuse Large B-cell Lymphoma
Ruonan Shao, Chengcheng Liu, Ruifeng Xue, et al.
International Journal of Biological Sciences (2024) Vol. 20, Iss. 3, pp. 848-863
Open Access | Times Cited: 24
Exosome-based anticancer vaccines: From Bench to bedside
Zhao Guo, Yuning Wang, Shujun Xing, et al.
Cancer Letters (2024) Vol. 595, pp. 216989-216989
Closed Access | Times Cited: 9
Single-cell histone chaperones patterns guide intercellular communication of tumor microenvironment that contribute to breast cancer metastases
Jindong Xie, Wei Deng, Xinpei Deng, et al.
Cancer Cell International (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 15
Global research trends on biomarkers for cancer immunotherapy: Visualization and bibliometric analysis
Yuan Qiao, Dong Xie, Zhengxiang Li, et al.
Human Vaccines & Immunotherapeutics (2025) Vol. 21, Iss. 1
Open Access
Emerging role of exosomes in cancer therapy: progress and challenges
Jiale Li, Jiachong Wang, Zigui Chen
Molecular Cancer (2025) Vol. 24, Iss. 1
Open Access
Integrating RNA-seq and scRNA-seq to explore the prognostic features and immune landscape of exosome-related genes in breast cancer metastasis
Guanyou Huang, Yong Yu, Heng Su, et al.
Annals of Medicine (2025) Vol. 57, Iss. 1
Open Access
Diffuse large B-cell lymphoma cell-derived exosomal NSUN2 stabilizes PDL1 to promote tumor immune escape and M2 macrophage polarization in a YBX1-dependent manner
Huayu Ling, Yuling Li, Panjun Wang, et al.
Archives of Biochemistry and Biophysics (2025), pp. 110322-110322
Closed Access
Clinical Impact of Exosome Chemistry in Cancer
Shrishti Madhan, Rajib Dhar, Arikketh Devi
ACS Applied Bio Materials (2025)
Closed Access
Click chemistry-based modified exosomes: Towards enhancing precision in cancer theranostics
Nobendu Mukerjee, Swastika Maitra, Mandeep Kaur, et al.
Chemical Engineering Journal (2025), pp. 160915-160915
Closed Access
Exosome-mediated communication between gastric cancer cells and macrophages: implications for tumor microenvironment
Yue Qiu, Guimei Lu, Na Li, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 4
Epigenetic deregulation in breast cancer microenvironment: Implications for tumor progression and therapeutic strategies
Lenka Trnkova, Verona Buociková, Michal Mego, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 174, pp. 116559-116559
Open Access | Times Cited: 4
Tumor Microenvironment-Derived Exosomes: A Double-Edged Sword for Advanced T Cell-Based Immunotherapy
Ye Lu, Jiarong Zheng, Pei Lin, et al.
ACS Nano (2024)
Closed Access | Times Cited: 4
Exosome-Like Systems: From Therapies to Vaccination for Cancer Treatment and Prevention—Exploring the State of the Art
Hamid Heydari Sheikhhossein, Francesca Iommelli, Natalia Di Pietro, et al.
(2024)
Open Access | Times Cited: 3
Exosome-like Systems: From Therapies to Vaccination for Cancer Treatment and Prevention—Exploring the State of the Art
Hamid Heydari Sheikh Hossein, Francesca Iommelli, Natalia Di Pietro, et al.
Vaccines (2024) Vol. 12, Iss. 5, pp. 519-519
Open Access | Times Cited: 3
CD8+ T cell exhaustion and its regulatory mechanisms in the tumor microenvironment: key to the success of immunotherapy
Biao Zhang, Jinming Liu, Yuying Mo, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 3
Exosome-based immunotherapy as an innovative therapeutic approach in melanoma
Shabnam Babaei, Manouchehr Fadaee, Hajar Abbasi‐Kenarsari, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 3
Immune Cell-Derived Exosomes: A Cell-Free Cutting-Edge Tumor Immunotherapy
Raj Sengupta, Ibrahim S. Topiwala, Antoine Gavoille, et al.
ACS Applied Bio Materials (2024) Vol. 7, Iss. 11, pp. 7076-7087
Closed Access | Times Cited: 3
Analysis of the effects of M2 macrophage‐derived PDE4C on the prognosis, metastasis and immunotherapy benefit of osteosarcoma
Feng Pan, Runsang Pan, Rui Hu, et al.
Journal of Cellular and Molecular Medicine (2024) Vol. 28, Iss. 10
Open Access | Times Cited: 2
The advancement of siRNA-based nanomedicine for tumor therapy
Muchuan Qiao, Chenlu Zeng, Changqing Liu, et al.
Nanomedicine (2024), pp. 1-22
Closed Access | Times Cited: 2
The involvement and application potential of exosomes in breast cancer immunotherapy
Yun Wang, Qiji Ma, Tielin Wang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
Tumor-associated macrophages derived exosomes; from pathogenesis to therapeutic opportunities
Sara Hadad, Amirreza Khalaji, Amirreza Jabbaripour Sarmadian, et al.
International Immunopharmacology (2024) Vol. 136, pp. 112406-112406
Closed Access | Times Cited: 1
Therapeutic combinations of exosomes alongside cancer stem cells (CSCs) and of CSC-derived exosomes (CSCEXs) in cancer therapy
Arefeh Zabeti Touchaei, Seyedeh Elham Norollahi, Ali Najafizadeh, et al.
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 1
Dual roles of extracellular vesicles in acute lymphoblastic leukemia: implications for disease progression and theranostic strategies
Mahya Sadat Lajevardi, Mahshad Ashrafpour, Shaden M.H. Mubarak, et al.
Medical Oncology (2024) Vol. 42, Iss. 1
Open Access | Times Cited: 1
CDK16 as a potential prognostic biomarker correlated with an immunosuppressive tumor microenvironment and benefits in enhancing the effectiveness of immunotherapy in human cancers
Juntao Qi, Gujie Wu, Min He, et al.
Aging (2024)
Open Access
The potential value of cancer‐testis antigens in ovarian cancer: Prognostic markers and targets for immunotherapy
Lina Lin, Xiaoqiong Zou, Weixia Nong, et al.
Immunity Inflammation and Disease (2024) Vol. 12, Iss. 6
Open Access
Page 1 - Next Page

Scroll to top